Bionano Genomics, Inc. (BNGO) CEO Erik Holmlin on Q2 2022 Re

Bionano Genomics, Inc. (NASDAQ:NASDAQ:BNGO) Q2 2022 Results Conference Call August 04, 2022 04:30 PM ET Company Participants Amy Conrad - Investor Relations Erik Holmlin - Chief Executive...

Related Keywords

China , San Diego , California , United States , Spain , Barcelona , Comunidad Autonoma De Cataluna , Spanish , American , Christopher Stewart , Jason Mccarthy , Erik Holmlin , Shamanna Kanagal , Amy Conrad , Chris Stewart , Michael Okunewitch , Company Participants , Laboratory Developed , Company Investor Relations , Bionano Genomics Inc , Jose Carreras Institute , Nasdaq , Cancer Genomics Consortium , Maxim Group , American Medical Association , Laboratory Analysis , Bionano Genomics , Conference Call August , Bionano Genomic Second Quarter , Results Conference , Investor Relations , Saphyr System , Forward Looking Statements , Accepted Accounting Principles , Optical Genome Mapping , Next Generation Sequencing , Myelodysplastic Syndrome , Saphyr Systems , Spanish Optical Genome Mapping , Hospital Del Mar , Long String , Medical Society , Laboratory Developed Tests , Optical Genome , Proprietary Laboratory Analysis , Homologous Recombination Deficiency ,